K Pharma,Inc. (TYO:4896)
Japan flag Japan · Delayed Price · Currency is JPY
674.00
-12.00 (-1.75%)
Nov 18, 2026, 10:21 AM JST

K Pharma,Inc. Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
---1,000--
Revenue Growth
------
Cost of Revenue
---90--
Gross Profit
---910--
Selling, General & Admin
579482380259353219
Research & Development
414414451255--
Other Operating Expenses
2020529--
Operating Expenses
1,013916836543353219
Operating Income
-1,013-916-836367-353-219
Interest Expense
-30-7----
Interest & Investment Income
63----
Currency Exchange Gain (Loss)
---1---
Other Non Operating Income (Expenses)
-3-2--24-7-1
EBT Excluding Unusual Items
-1,040-922-837343-360-220
Gain (Loss) on Sale of Assets
-61----31-8
Asset Writedown
-56-69-7-43--
Pretax Income
-1,157-991-844300-391-228
Income Tax Expense
222401-
Net Income
-1,159-993-846260-392-228
Net Income to Common
-1,159-993-846260-392-228
Net Income Growth
------
Shares Outstanding (Basic)
1212121098
Shares Outstanding (Diluted)
1212121198
Shares Change
0.11%0.00%2.97%20.79%22.75%-
EPS (Basic)
-99.76-85.57-72.9025.39-42.01-30.00
EPS (Diluted)
-99.76-85.57-72.9023.07-42.01-30.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--929-997445--
Free Cash Flow Per Share
--80.05-85.9139.48--
Gross Margin
---91.00%--
Operating Margin
---36.70%--
Profit Margin
---26.00%--
Free Cash Flow Margin
---44.50%--
EBIT
-1,013-916-836367-353-219
EBIT Margin
---36.70%--
Effective Tax Rate
---13.33%--